Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptic activity refers to the complex process of signal transmission between neurons at synapses, involving neurotransmitter release from presynaptic synaptic vesicles, diffusion across the synaptic cleft, and activation of postsynaptic receptors. This process underlies neural communication, synaptic plasticity, and various brain functions. It is not a single molecular entity or receptor, but rather a broad physiological event governed by the orchestration of many proteins, including ion channels, neurotransmitter receptors, synaptic vesicle-associated proteins, scaffolding molecules, and enzymes. Synaptic activity can be dysregulated in several neurological diseases, but it itself is not a therapeutic target; instead, drugs may target individual molecular components or signaling pathways that regulate synaptic activity.[3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptic activity.